Magnetic Resonance Imaging to Assess Changes in Meniscus Vascularity (MOVE)

February 18, 2016 updated by: The Leeds Teaching Hospitals NHS Trust

The menisci in the knee joint are important for normal functioning of the knee. Meniscus tears are amongst the commonest of injuries to the knee. The pattern and blood supply of the meniscus tears determines the treatment plan and outcome. The surgeon identifies the blood supply to the meniscus tear area during the arthroscopy(key hole operation) and decides the treatment option ie repair versus partial meniscectomy.

This study aims to identify any changes that occur in the meniscus blood supply. The following are the main aims of the 'MOVE'study-

  1. Use of non-invasive methods ie MRImaging to assess meniscus vascularity to preoperatively plan treatment and advice patient on recovery.
  2. The study would assess changes in meniscus blood supply depending on age of the patient.
  3. The study aims to assess the alteration in meniscus blood supply following an arthroscopic(key hole) meniscal repair operation.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

48

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Inclusion criteria for Group I,II

  1. Patients should be aged 18-20 years or 35-45years
  2. Asymptomatic knee for past 6 months.
  3. Painless flexion-extension movements at knee joint.

Inclusion criteria for Group III

  1. Patients should be aged 75 or older
  2. Knee X-ray showing no more than Kellgren-Lawrence grade II osteoarthrtis
  3. No clinical suspicion of meniscus tear
  4. Painless flexion-extension movements at knee joint.

Inclusion criteria for Group IV

1. Patients should have presented with clinical signs to suggest meniscus tear indicating potential need for surgical meniscus repair.

Exclusion Criteria:

  1. Proven Polyarthritis / Polyarthralgia secondary to Rheumatoid arthritis, Gout, Lupus, Ankylosing Spondylosis, Psoriatic arthritis
  2. Any previous surgical procedure(open or arthroscopic) involving the knee joint.(baring the current meniscus repair in Group IV participants)
  3. Patients unable to give informed consent.
  4. Patients with contraindication for MR Imaging - Metal implants, prosthetic heart valves, pacemakers, metal foreign bodies, VP shunts, pregnancy, cochlear implant, metal clips in the brain, Patients with static tremor i.e. Parkinson's disease.
  5. Patients with contraindications for contrast agent - Renal impairment, Previous allergic reaction.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Group One patients in age group 18--20 years,
  1. Patients should be aged 18--20 years or 35--45years
  2. Asymptomatic knee for past 6 months.
  3. Painless flexion-extension movements at knee joint.
Active Comparator: Group Two patients in age group 35-45 years,
  1. Patients should be aged 18--20 years or 35--45years
  2. Asymptomatic knee for past 6 months.
  3. Painless flexion-extension movements at knee joint.
Active Comparator: Group Three Patients aged 75
  1. Patients should be aged 75 or older
  2. Knee X-ray showing no more than Kellgren-Lawrence grade II osteoarthrtis
  3. No clinical suspicion of meniscus tear
  4. Painless flexion-extension movements at knee joint.
Active Comparator: Group Four, any age due to undergo a surgical meniscus repair
1. Patients should have presented with clinical signs to suggest meniscus tear indicating potential need for surgical meniscus repair

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Primary outcome is to assess meniscus vascularity in-vivo by use of MR imaging technique.
Time Frame: 6 months
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2012

Primary Completion (Actual)

June 1, 2015

Study Registration Dates

First Submitted

February 9, 2015

First Submitted That Met QC Criteria

February 12, 2015

First Posted (Estimate)

February 13, 2015

Study Record Updates

Last Update Posted (Estimate)

February 19, 2016

Last Update Submitted That Met QC Criteria

February 18, 2016

Last Verified

February 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • OR11/9770

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Meniscus Tears

Clinical Trials on Will undergo a single MRI assessment with intravenous dye

3
Subscribe